|
| ID |
DDInter606 |
| Drug Type |
small molecule |
| Molecular Formula |
C9H11No5 |
| Molecular Weight |
213.189
|
| Description |
Droxidopa is a medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease.
|
| ATC Classification |
C01CA27
|
| IUPAC Name |
(2S,3R)-2-Amino-3-(3,4-Dihydroxyphenyl)-3-Hydroxypropanoic Acid |
| InChI |
Inchi=1S/C9H11No5/C10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/H1-3,7-8,11-13H,10H2,(H,14,15)/T7-,8+/M0/S1 |
| InChI Key |
QXWYKJLNLSIPIN-JGVFFNPUSA-N |
| Canonical SMILES |
N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O |
| Useful Links |
DrugBank
ChEMBL
PubChem
|